| Investor | Bridger Management, Llc |
13D/G Filings
This page shows a list of all the recent 13D/G filings made by Bridger Management, Llc . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).
When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.
| Date | Form | Target | Prev Shares |
Current Shares |
Change (Percent) |
Ownership (Percent) |
Change (Percent) |
|
|---|---|---|---|---|---|---|---|---|
| 2022-02-14 | 13G/A | SRZN / Surrozen, Inc. | 700,000 | 0 | ||||
| 2021-02-16 | 13G/A | ATRA / Atara Biotherapeutics, Inc. | 2,932,865 | 1,524,760 | ||||
| 2020-11-30 | 13G | SRZN / Surrozen, Inc. | 700,000 | |||||
| 2020-02-14 | 13G/A | TGTX / TG Therapeutics, Inc. | 4,991,531 | 1,907,492 | ||||
| 2020-02-14 | 13G/A | ATRA / Atara Biotherapeutics, Inc. | 2,932,865 | 2,932,865 | ||||
| 2020-02-14 | 13G/A | DRNA / Dicerna Pharmaceuticals Inc | 4,773,718 | 1,981,633 | ||||
| 2019-11-01 | 13G | ATRA / Atara Biotherapeutics, Inc. | 2,206,917 | 2,932,865 | ||||
| 2019-03-11 | 13G | TGTX / TG Therapeutics, Inc. | 3,791,531 | 4,991,531 | ||||
| 2019-02-14 | 13G/A | DRNA / Dicerna Pharmaceuticals Inc | 3,056,779 | 4,773,718 | ||||
| 2019-02-14 | 13G/A | ATRA / Atara Biotherapeutics, Inc. | 2,598,599 | 2,206,917 | ||||
| 2019-02-14 | 13G/A | TGTX / TG Therapeutics, Inc. | 4,391,634 | 3,791,531 | ||||
| 2018-06-21 | 13G | DRNA / Dicerna Pharmaceuticals Inc | 3,056,779 | |||||
| 2018-02-14 | 13G/A | ATRA / Atara Biotherapeutics, Inc. | 1,524,191 | 2,598,599 | ||||
| 2018-02-14 | 13G/A | TGTX / TG Therapeutics, Inc. | 4,921,059 | 4,391,634 | ||||
| 2017-04-21 | 13G | ATRA / Atara Biotherapeutics, Inc. | 1,524,191 | |||||
| 2017-02-14 | 13G/A | PACB / Pacific Biosciences of California, Inc. | 4,462,170 | 0 | ||||
| 2017-02-14 | 13G/A | CMRX / Chimerix, Inc. | 2,967,186 | 0 | ||||
| 2017-02-14 | 13G/A | SPNE / SeaSpine Holdings Corp | 618,684 | 0 | ||||
| 2017-02-14 | 13G/A | TGTX / TG Therapeutics, Inc. | 3,430,367 | 4,921,059 | ||||
| 2017-02-14 | 13G/A | TROV / TrovaGene, Inc. | 2,460,626 | 0 | ||||
| 2016-11-15 | 13G | TROV / TrovaGene, Inc. | 3,290,587 | 2,460,626 | ||||
| 2016-04-25 | 13G | PACB / Pacific Biosciences of California, Inc. | 4,462,170 | |||||
| 2016-04-05 | 13D | TROV / TrovaGene, Inc. | 3,290,587 | 3,290,587 | ||||
| 2016-02-16 | 13G/A | ARWR / Arrowhead Pharmaceuticals, Inc. | 0 | |||||
| 2016-02-16 | 13G/A | PFSI / PennyMac Financial Services, Inc. | 0 | |||||
| 2016-02-16 | 13G/A | SPNE / SeaSpine Holdings Corp | 618,684 | 618,684 | ||||
| 2016-02-16 | 13G/A | TROV / TrovaGene, Inc. | 3,290,587 | |||||
| 2016-02-16 | 13G/A | TGTX / TG Therapeutics, Inc. | 3,154,988 | 3,430,367 | ||||
| 2016-01-19 | 13G | CMRX / Chimerix, Inc. | 2,967,186 | |||||
| 2015-11-20 | 13G/A | RGDXQ / Response Genetics, Inc | 7,351,352 | 1,351,352 | ||||
| 2015-10-05 | 13G | TGTX / TG Therapeutics, Inc. | 3,154,988 | |||||
| 2015-07-20 | 13G | SPNE / SeaSpine Holdings Corp | 618,684 | |||||
| 2015-04-08 | 13G/A | RGDXQ / Response Genetics, Inc | 7,351,352 | |||||
| 2015-02-17 | 13G/A | MDCO / Medicines Company | 2,349,247 | |||||
| 2015-02-17 | 13G/A | ECOM / ChannelAdvisor Corp | 0 | |||||
| 2015-02-17 | 13G/A | TROV / TrovaGene, Inc. | 2,587,301 | |||||
| 2015-02-17 | 13G/A | PFSI / PennyMac Financial Services, Inc. | 2,025,000 | |||||
| 2015-02-17 | 13G/A | ARAY / Accuray Incorporated | 3,903,090 | |||||
| 2015-02-17 | 13G/A | WMGIZ / Wright Medical Group N.V. | 0 | |||||
| 2015-02-17 | 13G/A | TGTX / TG Therapeutics, Inc. | 1,869,530 | |||||
| 2015-01-23 | 13G | ARWR / Arrowhead Pharmaceuticals, Inc. | 2,984,183 | |||||
| 2014-10-20 | 13G | MDCO / Medicines Company | 3,308,151 | |||||
| 2014-09-08 | 13G | ARAY / Accuray Incorporated | 3,884,853 | |||||
| 2014-08-18 | 13G | WMGIZ / Wright Medical Group N.V. | 2,699,052 | |||||
| 2014-08-15 | 13G/A | ECOM / ChannelAdvisor Corp | 2,170,993 | |||||
| 2014-08-01 | 13G | ECOM / ChannelAdvisor Corp | 1,670,993 | |||||
| 2014-02-14 | 13G/A | 98235T107 / Wright Medical Group N.V. | 1,263,284 | |||||
| 2014-02-14 | 13G/A | PRMW / Primo Water Corporation | 4,550,000 | |||||
| 2014-01-31 | 13G | TGTX / TG Therapeutics, Inc. | 2,394,132 | |||||
| 2014-01-13 | 13G/A | RGDXQ / Response Genetics, Inc | 6,000,000 | |||||
| 2014-01-13 | 13G/A | TROV / TrovaGene, Inc. | 2,142,857 | |||||
| 2014-01-13 | 13G/A | PFSI / PennyMac Financial Services, Inc. | 1,725,000 | |||||
| 2013-08-09 | 13G | TROV / TrovaGene, Inc. | 2,142,857 | |||||
| 2013-05-22 | 13G/A | PFSI / PennyMac Financial Services, Inc. | 1,500,000 | |||||
| 2013-05-20 | 13G | PFSI / PennyMac Financial Services, Inc. | 1,500,000 | |||||
| 2013-02-14 | 13G/A | 98235T107 / Wright Medical Group N.V. | 2,124,983 | |||||
| 2013-02-14 | 13G/A | URI / United Rentals, Inc. | 1,015,063 | |||||
| 2013-02-14 | 13G/A | CRME / Cardiome Pharma Corp. | 0 | |||||
| 2013-02-14 | 13G/A | PRMW / Primo Water Corporation | 6,617,855 | |||||
| 2013-02-14 | 13G/A | CWST / Casella Waste Systems, Inc. | 1,793,507 | |||||
| 2012-10-26 | 13G | 98235T107 / Wright Medical Group N.V. | 2,000,000 | |||||
| 2012-10-03 | 13G/A | RGDXQ / Response Genetics, Inc | 6,000,000 | |||||
| 2012-02-14 | 13G/A | CRME / Cardiome Pharma Corp. | 3,389,830 | |||||
| 2012-02-14 | 13G/A | STAR / iStar Inc | 1,792,712 | |||||
| 2012-02-14 | 13G/A | URI / United Rentals, Inc. | 3,711,283 | |||||
| 2012-02-14 | 13G/A | IRWD / Ironwood Pharmaceuticals, Inc. | 1,879,375 | |||||
| 2012-02-14 | 13G/A | PMT / PennyMac Mortgage Investment Trust | 1,056,862 | |||||
| 2012-02-14 | 13G/A | PRMW / Primo Water Corporation | 6,617,855 | |||||
| 2012-02-14 | 13G/A | CWST / Casella Waste Systems, Inc. | 1,793,507 | |||||
| 2012-02-13 | 13G | RGDXQ / Response Genetics, Inc | 3,000,000 |
